MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.79 Cr | ₹0.75 Cr | ₹0.48 Cr | ₹0.69 Cr | ₹1.15 Cr |
What is the latest Contingent Liabilities ratio of MERCURY LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.79 Cr |
Mar2023 | ₹0.75 Cr |
Mar2022 | ₹0.48 Cr |
Mar2021 | ₹0.69 Cr |
Mar2020 | ₹1.15 Cr |
How is Contingent Liabilities of MERCURY LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.79 Cr | 5.35 | |
Mar2023 | ₹0.75 Cr | 55.63 | |
Mar2022 | ₹0.48 Cr | -30.23 | |
Mar2021 | ₹0.69 Cr | -39.97 | |
Mar2020 | ₹1.15 Cr | - |
Compare Contingent Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹112.9 Cr | -1.3% | -2.3% | 19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,914.0 Cr | -0.7% | -6.2% | 52.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -3.1% | -5.5% | 66.2% | Stock Analytics | |
CIPLA | ₹121,563.0 Cr | -4.3% | -4.2% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,939.0 Cr | -3.2% | -5.9% | 16.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,960.7 Cr | -0.9% | -8.9% | 53.3% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -1.3% |
-2.3% |
19.6% |
SENSEX | -3.3% |
-5.2% |
19.8% |
You may also like the below Video Courses